Merus N.V. CS (MRUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MRUS | HALO | RYTM | ||
| Company | Merus N.V. CS | Halozyme Therapeutic | Rhythm Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 96.11 | 62.87 | 104.63 | ||
| High | 96.27 | 66.00 | 107.57 | ||
| Low | 96.01 | 61.70 | 102.76 | ||
| Latest | 96.22 | 62.95 | 105.70 | ||
| Change | +0.10 | -1.71 | +1.07 | ||
| % Change | +0.10% | -2.64% | +1.02% | ||
| Volume | 1,425,900 | 4,213,500 | 575,800 | ||
| 20-Day Average Volume | 1,419,385 | 2,778,750 | 711,680 | ||
| Previous Close | 96.12 | 64.66 | 104.63 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 95.86 | 69.50 | 102.24 | ||
| 20-Day Raw Stochastic | 95.24% | 9.96% | 70.81% | ||
| 20-Day Relative Strength | 75.63 | 36.60 | 52.43 | ||
| Weighted Alpha | +83.63 | +22.60 | +62.42 | ||
| Today's Opinion | 100% Buy | 8% Buy | 80% Buy | ||
| Previous Opinion | 100% Buy | 40% Buy | 80% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.14% since 11/26/25 | -13.36% since 11/26/25 | -1.60% since 11/26/25 | ||
| Low | 95.83 on 12/02/25 | 61.70 on 12/04/25 | 101.00 on 12/02/25 | ||
| High | 96.27 on 12/04/25 | 72.78 on 11/28/25 | 110.00 on 11/28/25 | ||
| 1-Month | |||||
| %Chg | +1.24% since 11/04/25 | -7.49% since 11/04/25 | +0.68% since 11/04/25 | ||
| Low | 94.92 on 11/05/25 | 61.70 on 12/04/25 | 95.27 on 11/07/25 | ||
| High | 96.28 on 11/14/25 | 74.25 on 11/26/25 | 110.00 on 11/28/25 | ||
| 3-Month | |||||
| %Chg | +45.28% since 09/04/25 | -14.24% since 09/04/25 | +1.08% since 09/04/25 | ||
| Low | 65.61 on 09/05/25 | 61.70 on 12/04/25 | 94.39 on 09/15/25 | ||
| High | 96.28 on 11/14/25 | 79.50 on 09/23/25 | 116.00 on 10/30/25 | ||
| 6-Month | |||||
| %Chg | +67.11% since 06/04/25 | +16.90% since 06/04/25 | +64.14% since 06/04/25 | ||
| Low | 51.78 on 07/08/25 | 51.06 on 06/30/25 | 60.70 on 06/18/25 | ||
| High | 96.28 on 11/14/25 | 79.50 on 09/23/25 | 116.00 on 10/30/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,297,999 | 7,402,731 | 7,053,995 | ||
| Shares Outstanding, K | 75,847 | 117,597 | 66,736 | ||
| Annual Sales | 36,130,000 | 1,015,320,000 | 130,130,000 | ||
| Annual Net Income | -215,330,000 | 444,090,000 | -260,600,000 | ||
| Last Quarter Sales | 12,150,000 | 354,260,000 | 51,300,000 | ||
| Last Quarter Net Income | -95,520,000 | 175,230,000 | -52,900,000 | ||
| 60-Month Beta | 1.06 | 0.95 | 1.96 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.23 on 10/31/25 | 1.72 on 11/03/25 | -0.82 on 11/04/25 | ||
| Latest Earnings Date | 10/30/25 | 11/03/25 | 11/04/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 12.15 | 0.00 | ||